Experts from Comprehend and Tufts CSDD to discuss the recent study, outline where the industry is headed and ways to overcome oversight challenges including transparency, risk, and compliance
Live discussion with FDA and Siemens to provide an overview of the use of individualized computer simulation to predict clinical outcomes in medical device trials
Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development
RenovoDerm's Phoenix Wound Matrix supports healthy tissue growth and promotes faster, definitive wound healing.
Adds 4 trademarks - Nutrafer™, Dietofer™ and IDAXTM in Iron Deficiency and TolPlus™ in Gluten Intolerance
Presenters discuss how clinical innovators, Market Access, IT and HEOR can accelerate RWE initiatives and the implications for data security and healthcare decision-making
Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins
Presenters will focus on the role of an abuse potential assessment (also referred to as the Controlled Substances Act 8-factor analysis) in the development of cannabinoid products and how it relates to the U.S. scheduling process, and related interactions with the FDA and DEA
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.